Minneapolis, MN, February 24, 2016 --(PR.com
)-- IMRIS, Deerfield Imaging, the global leader in intraoperative imaging, today announced that its board of directors has appointed Andrew M. Flanagan as President and Chief Executive Officer effective February 22, 2016. As CEO, Mr. Flanagan succeeds Jay D. Miller, who resigned his position as President and CEO on January 31.
Mr. Flanagan has over 25 years of high-tech experience and is a highly accomplished leader. He has an impressive track record of growing business through establishing successful long-term global relationships with healthcare professionals and partners. He joins IMRIS with senior leadership experience from Siemens Healthcare, SAP and Xerox, as well as serving as CEO for several different high growth companies. Driven with a passion for patience-centricity and healthcare innovation, IMRIS is perfectly positioned to leverage his strong operational and leadership skills.
“The IMRIS Board and I are thrilled to have Andy join the company,” said Gregory Sorensen, M.D., Executive Chairman, IMRIS, Deerfield Imaging Board of Directors. “It is further testimony to the attractiveness of our solutions and the vibrancy of our business that a leader of Andrew’s caliber and accomplishments is coming to lead IMRIS forward.”
Dr. Sorensen, who has also been serving as an interim CEO, will return to focusing exclusively on his role as Executive Chairman of IMRIS, Deerfield Imaging Board of Directors as of February 22.
“IMRIS has an extraordinary opportunity to deliver differentiated value to the world’s leading neurological centers by providing the only, truly intraoperative surgical solution which is designed to support surgeons before, during and after surgery without moving the patient,” said company President and CEO Andrew Flanagan. “I am honored to have been asked to take the role, and am excited about the future possibilities.”
About IMRIS, Deerfield Imaging
As a leader in image guided therapy solutions, IMRIS®, Deerfield Imaging provide optimized fully integrated image-guided therapy environments that serve to address the important needs of patients, clinicians and hospitals by delivering timely information on surgical targets and results to clinicians for use during surgical or interventional procedures. The VISIUS® Surgical Theatre incorporates MRI, CT and angiography into multi-purpose surgical suites to provide advanced intraoperative imaging directly in operating rooms. IMRIS products are sold globally to hospitals in the neurosurgical, spinal, cardiovascular, and orthopedic markets.
For more information, call +1.763.203.6300, email firstname.lastname@example.org or visit www.imris.com.